Condensed Consolidated Statements of Stockholders' Equity and Accumulated Other Comprehensive Loss - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive loss
Balance beginning (in shares) at Dec. 31, 2021		141,301,569
Balance beginning at Dec. 31, 2021	$ 303,510	$ 16	$ 361,542	$ (56,797)	$ (1,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		117,420
Common stock issued upon exercise of stock options	34		34
Stock-based compensation	1,194		1,194
Net income	7,346			7,346
Other Comprehensive (loss) income	(3,690)				(3,690)
Ending balance at Mar. 31, 2022	308,394	$ 16	362,770	(49,451)	(4,941)
Ending balance (in shares) at Mar. 31, 2022		141,418,989
Balance beginning (in shares) at Dec. 31, 2022		143,034,225
Balance beginning at Dec. 31, 2022	376,905	$ 14	371,072	21,772	(15,953)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		163,096
Common stock issued upon exercise of stock options	23		23
Vested common stock awards (in shares)		70,670
Vested common stock awards	0
Stock-based compensation	2,915		2,915
Net income	9,769			9,769
Other Comprehensive (loss) income	1,530				1,530
Ending balance at Mar. 31, 2023	$ 391,142	$ 14	$ 374,010	$ 31,541	$ (14,423)
Ending balance (in shares) at Mar. 31, 2023		143,267,991